Integral Health Asset Management, LLC Nurix Therapeutics, Inc. Transaction History
Integral Health Asset Management, LLC
- $1.32 Billion
- Q3 2025
A detailed history of Integral Health Asset Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 350,000 shares of NRIX stock, worth $4.48 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
350,000
Previous 310,000
12.9%
Holding current value
$4.48 Million
Previous $3.53 Million
8.39%
% of portfolio
0.25%
Previous 0.36%
Shares
6 transactions
Others Institutions Holding NRIX
# of Institutions
183Shares Held
77.6MCall Options Held
99.8KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$87.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.06MShares$77.5 Million1.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.49MShares$57.5 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$49.7 Million0.29% of portfolio
-
Commodore Capital LP New York, NY3.78MShares$48.4 Million2.23% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $603M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...